Liver Complications Following Treatment of Hematologic Malignancy With Anti-Cd22-Calicheamicin (Inotuzumab Ozogamicin)
Hepatology - United States
doi 10.1002/hep.30222
Full Text
Open PDFAbstract
Available in full text
Date
January 18, 2019
Authors
Publisher
Wiley